Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021–23
Article in Vaccine (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Vaccine (April 2024)
Article in Vaccine (October 2023)
Article in Vaccines (September 2023)